Manufacturing capacity and capabilities

Capacity and Capabilities

When custom products are considered, assessing the capacity is always product dependent; the higher the overall production yield, the higher the output with the facilities and existing equipment and therefore the larger the capacity.

The PolyPeptide Group offers the flexible capability of Liquid Phase, Solid Phase, or Hybrid approaches for peptide synthesis.  Additional details are provided in the “Technology” section.

Not all commercial peptides require large quantities, however, for those projects that require high output, PolyPeptide offers a manufacturing capacity of up to 250 kg of peptide using Liquid Phase Peptide Synthesis, and up to 500 kg using the Solid Phase Peptide Synthesis approach.

Learn more